Final days to save 20% off DTRF "Together We Will" Weekend tickets. - Register today!

May 2024

Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?

Author Information

Thierry Alcindor 1

1Center for Sarcoma, Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Publication

JCO Glob Oncol

Summary

Thalcin explains how a metronomic regimen for desmoid tumors fits in the current treatment landscape.